2023-04622. Center for Scientific Review; Notice of Meeting

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should register at: https://public.csr.nih.gov/​AboutCSR/​Organization/​CSRAdvisoryCouncil/​Registration.

The meeting can be viewed remotely via the NIH Videocasting website: https://videocast.nih.gov/​watch=​49156.

Name of Committee: Center for Scientific Review Advisory Council.

Date: March 27, 2023.

Time: 10:00 a.m. to 3:00 p.m.

Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR.

Place: National Institutes of Health, 6701 Rockledge Drive, Conference Room 160A, Bethesda, MD 20892.

Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, [phone], [e-mail].

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has stringent procedures for entrance into NIH federal property. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID-19 Safety Plan at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​Pages/​default.aspx for information about requirements and procedures for entering NIH facilities, especially when the COVID-19 community level is medium. If the COVID-19 level is high, the meeting will be held virtually. In addition, the Safer Federal Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/​faq/​visitors/​. Please note that if an individual has a COVID-19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH's Requirements for Persons after Exposure at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​COVID-assessment-testing/​Pages/​persons-after-exposure.aspx and What Happens When Someone Tests Positive at https://ors.od.nih.gov/​sr/​dohs/​safety/​NIH-covid-19-safety-plan/​COVID-assessment-testing/​Pages/​test-positive.aspx.) Anyone from the public can attend the meeting virtually via the NIH Videocasting website ( http://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up-to-date guidance as the meeting date approaches.

Information is also available on the Institute's/Center's home page: https://public.csr.nih.gov/​AboutCSR/​Organization/​CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: March 1, 2023.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.